189 related articles for article (PubMed ID: 7824089)
1. Coisogenic all-plus-one immunization: a model for identifying missing proteins in null-mutant conditions. Antibodies to dystrophin in mdx mouse after transplantation of muscle from normal coisogenic donor.
Bittner RE; Streubel B; Shorny S; Schaden G; Voit T; Höger H
Neuropediatrics; 1994 Aug; 25(4):176-82. PubMed ID: 7824089
[TBL] [Abstract][Full Text] [Related]
2. Adeno-associated virus vector-mediated gene transfer into dystrophin-deficient skeletal muscles evokes enhanced immune response against the transgene product.
Yuasa K; Sakamoto M; Miyagoe-Suzuki Y; Tanouchi A; Yamamoto H; Li J; Chamberlain JS; Xiao X; Takeda S
Gene Ther; 2002 Dec; 9(23):1576-88. PubMed ID: 12424610
[TBL] [Abstract][Full Text] [Related]
3. Transient immunosuppression by FK506 permits a sustained high-level dystrophin expression after adenovirus-mediated dystrophin minigene transfer to skeletal muscles of adult dystrophic (mdx) mice.
Lochmüller H; Petrof BJ; Pari G; Larochelle N; Dodelet V; Wang Q; Allen C; Prescott S; Massie B; Nalbantoglu J; Karpati G
Gene Ther; 1996 Aug; 3(8):706-16. PubMed ID: 8854096
[TBL] [Abstract][Full Text] [Related]
4. The effects of dystrophin gene mutations on the ERG in mice and humans.
Cibis GW; Fitzgerald KM; Harris DJ; Rothberg PG; Rupani M
Invest Ophthalmol Vis Sci; 1993 Dec; 34(13):3646-52. PubMed ID: 8258524
[TBL] [Abstract][Full Text] [Related]
5. Helper (CD4(+)) and cytotoxic (CD8(+)) T cells promote the pathology of dystrophin-deficient muscle.
Spencer MJ; Montecino-Rodriguez E; Dorshkind K; Tidball JG
Clin Immunol; 2001 Feb; 98(2):235-43. PubMed ID: 11161980
[TBL] [Abstract][Full Text] [Related]
6. Dystrophin acts as a transplantation rejection antigen in dystrophin-deficient mice: implication for gene therapy.
Ohtsuka Y; Udaka K; Yamashiro Y; Yagita H; Okumura K
J Immunol; 1998 May; 160(9):4635-40. PubMed ID: 9574572
[TBL] [Abstract][Full Text] [Related]
7. Immune responses to dystropin: implications for gene therapy of Duchenne muscular dystrophy.
Ferrer A; Wells KE; Wells DJ
Gene Ther; 2000 Sep; 7(17):1439-46. PubMed ID: 11001363
[TBL] [Abstract][Full Text] [Related]
8. [Presence of dystrophine-like protein at the neuromuscular junction in Duchenne muscular dystrophy and in "mdx" mutant mice].
Fardeau M; Tomé FM; Collin H; Augier N; Pons F; Léger J; Léger J
C R Acad Sci III; 1990; 311(5):197-204. PubMed ID: 2119867
[TBL] [Abstract][Full Text] [Related]
9. Smooth muscle-specific dystrophin expression improves aberrant vasoregulation in mdx mice.
Ito K; Kimura S; Ozasa S; Matsukura M; Ikezawa M; Yoshioka K; Ueno H; Suzuki M; Araki K; Yamamura K; Miwa T; Dickson G; Thomas GD; Miike T
Hum Mol Genet; 2006 Jul; 15(14):2266-75. PubMed ID: 16777842
[TBL] [Abstract][Full Text] [Related]
10. Targeted disruption of exon 52 in the mouse dystrophin gene induced muscle degeneration similar to that observed in Duchenne muscular dystrophy.
Araki E; Nakamura K; Nakao K; Kameya S; Kobayashi O; Nonaka I; Kobayashi T; Katsuki M
Biochem Biophys Res Commun; 1997 Sep; 238(2):492-7. PubMed ID: 9299538
[TBL] [Abstract][Full Text] [Related]
11. Improvement in survival and muscle function in an mdx/utrn(-/-) double mutant mouse using a human retinal dystrophin transgene.
Gaedigk R; Law DJ; Fitzgerald-Gustafson KM; McNulty SG; Nsumu NN; Modrcin AC; Rinaldi RJ; Pinson D; Fowler SC; Bilgen M; Burns J; Hauschka SD; White RA
Neuromuscul Disord; 2006 Mar; 16(3):192-203. PubMed ID: 16487708
[TBL] [Abstract][Full Text] [Related]
12. Immune evasion by muscle-specific gene expression in dystrophic muscle.
Hartigan-O'Connor D; Kirk CJ; Crawford R; Mulé JJ; Chamberlain JS
Mol Ther; 2001 Dec; 4(6):525-33. PubMed ID: 11735336
[TBL] [Abstract][Full Text] [Related]
13. Immunological detection of the dystrophin molecule with antibody directed against the synthetic peptide.
Ohta M; Ohta K; Hara H; Itoh N; Itagaki Y; Nishitani H; Hayashi K
Biochem Int; 1991 Dec; 25(6):1087-93. PubMed ID: 1810253
[TBL] [Abstract][Full Text] [Related]
14. Eosinophilia of dystrophin-deficient muscle is promoted by perforin-mediated cytotoxicity by T cell effectors.
Cai B; Spencer MJ; Nakamura G; Tseng-Ong L; Tidball JG
Am J Pathol; 2000 May; 156(5):1789-96. PubMed ID: 10793090
[TBL] [Abstract][Full Text] [Related]
15. Ex vivo gene transfer using adenovirus-mediated full-length dystrophin delivery to dystrophic muscles.
Floyd SS; Clemens PR; Ontell MR; Kochanek S; Day CS; Yang J; Hauschka SD; Balkir L; Morgan J; Moreland MS; Feero GW; Epperly M; Huard J
Gene Ther; 1998 Jan; 5(1):19-30. PubMed ID: 9536261
[TBL] [Abstract][Full Text] [Related]
16. Immune rejection of human dystrophin following intramuscular injections of naked DNA in mdx mice.
Braun S; Thioudellet C; Rodriguez P; Ali-Hadji D; Perraud F; Accart N; Balloul JM; Halluard C; Acres B; Cavallini B; Pavirani A
Gene Ther; 2000 Sep; 7(17):1447-57. PubMed ID: 11001364
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of dystrophin in transgenic mdx mice eliminates dystrophic symptoms without toxicity.
Cox GA; Cole NM; Matsumura K; Phelps SF; Hauschka SD; Campbell KP; Faulkner JA; Chamberlain JS
Nature; 1993 Aug; 364(6439):725-9. PubMed ID: 8355788
[TBL] [Abstract][Full Text] [Related]
18. Dmd(mdx-beta geo): a new allele for the mouse dystrophin gene.
Wertz K; Füchtbauer EM
Dev Dyn; 1998 Jun; 212(2):229-41. PubMed ID: 9626497
[TBL] [Abstract][Full Text] [Related]
19. A highly functional mini-dystrophin/GFP fusion gene for cell and gene therapy studies of Duchenne muscular dystrophy.
Li S; Kimura E; Ng R; Fall BM; Meuse L; Reyes M; Faulkner JA; Chamberlain JS
Hum Mol Genet; 2006 May; 15(10):1610-22. PubMed ID: 16595609
[TBL] [Abstract][Full Text] [Related]
20. Temporal gene expression profiling of dystrophin-deficient (mdx) mouse diaphragm identifies conserved and muscle group-specific mechanisms in the pathogenesis of muscular dystrophy.
Porter JD; Merriam AP; Leahy P; Gong B; Feuerman J; Cheng G; Khanna S
Hum Mol Genet; 2004 Feb; 13(3):257-69. PubMed ID: 14681298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
